B01J2231/4288

PROCESS FOR PREPARING DOUBLE METAL CYANIDE CATALYSTS
20250360495 · 2025-11-27 ·

The present invention relates to an improved process for preparing double metal cyanide (DMC) catalysts for the preparation of polyoxyalkylene polyols, preferably polyether polyols and/or polyether carbonate polyols. The invention further provides DMC catalysts which are obtainable by this process and for the use of the catalysts according to the invention for preparing polyoxyalkylene polyols.

CATALYSTS FOR SYNTHESIZING CYCLIC CARBONATES, PREPARATION METHODS AND USES THEREOF

The present invention provides a catalyst for synthesizing a cyclic carbonate and a preparation method and use thereof. A diamine compound X, a salicylaldehyde-containing compound and a metal source M are subjected to reaction, and then added with a phenothiazine compound Y for continuous reaction to obtain a phenothiazine metal Schiff base catalyst. The formation of phenothiazine free radicals by phenothiazine compounds with a central metal can protect the central metal in the course of reaction and inhibit inactivation caused by the self-polymerization of the central meta, thus improving the activity and stability of a catalyst. Phenothiazine compounds can be present as a polymerization inhibitor to inhibit the generation of by-products such as polycarbonates and polyethylene glycol and enhance the selectivity of the catalyst during the reaction. The phenothiazine compounds are alkaline and can adsorb and activate carbon dioxide during reaction, which helps to improve the reaction efficiency. The phenothiazine metal Schiff base catalyst prepared in the present invention has high activity, strong stability and good selectivity and thus, can achieve the efficient catalyzed synthesis of cyclic carbonates under mild conditions.

Catalysts for synthesizing cyclic carbonates, preparation methods and uses thereof

The present invention provides a catalyst for synthesizing a cyclic carbonate and a preparation method and use thereof. A diamine compound X, a salicylaldehyde-containing compound and a metal source M are subjected to reaction, and then added with a phenothiazine compound Y for continuous reaction to obtain a phenothiazine metal Schiff base catalyst. The formation of phenothiazine free radicals by phenothiazine compounds with a central metal can protect the central metal in the course of reaction and inhibit inactivation caused by the self-polymerization of the central meta, thus improving the activity and stability of a catalyst. Phenothiazine compounds can be present as a polymerization inhibitor to inhibit the generation of by-products such as polycarbonates and polyethylene glycol and enhance the selectivity of the catalyst during the reaction. The phenothiazine compounds are alkaline and can adsorb and activate carbon dioxide during reaction, which helps to improve the reaction efficiency. The phenothiazine metal Schiff base catalyst prepared in the present invention has high activity, strong stability and good selectivity and thus, can achieve the efficient catalyzed synthesis of cyclic carbonates under mild conditions.

EVOLVING RANDOM HETEROPOLYMERS TOWARDS CATALYTICALLY ACTIVE MATERIALS

The present disclosure relates to using monomer-based heteropolymers to create random heteropolymers that act as biomimetic catalysts that can be evolved to mimic activities of different classes of natural enzymes. The random heteropolymers comprise a mixture of heteropolymer sequences wherein a portion of the heteropolymers comprise a catalytically active region similar to that of a naturally occurring enzyme active site.

Method for producing fluorine-containing olefin

A production method of producing a fluorine-containing olefin by allowing a first olefin represented by the following Formula (1) and a second olefin to react with each other in the presence of a ruthenium compound represented by the following Formula (X) is provided. ##STR00001##

PROCESS FOR MANUFACTURING ALOGABAT

The invention relates to novel processes for manufacturing 6-[[5-methyl-3-(6-methyl-3-pyridyl)isoxazol-4-yl]methoxy]-N-tetrahydropyran-4-yl-pyridazine-3-carboxamide (1), or a pharmaceutically acceptable salt thereof. The processes according to the invention are particularly suitable for large-scale manufacturing of the compound of formula 1 under GMP conditions.

##STR00001##